The RASCAD trial investigated the potential benefit of renal artery revascularization versus medical therapy in patients with renal artery stenosis and coronary artery disease. Surprisingly, renal artery stenting seemed to convey no benefit on left ventricular mass. Has all been said and done about renal artery revascularization?
- Lars Christian Rump
- Lorenz Sellin